Vice President of Scientific Affairs and Distinguished Research Scholar for Infectious Diseases, Eli Lilly and Company
Dr. Gail Cassell is on the Board of Advisors and is chair of the Scientific Steering Committee of The Lilly TB Drug Discovery Initiative. She is vice president of scientific affairs and distinguished research scholar for infectious diseases at Eli Lilly and Company. Prior to joining Lilly in 1997, she served as the Charles H. McCauley Professor and chair of the Department of Microbiology at the University of Alabama Schools of Medicine and Dentistry in Birmingham, Alabama, a department that ranked first in research funding from the National Institutes of Health (NIH) during the decade of her leadership.
Currently Dr. Cassell is a member of the Science Board of the Federal Food and Drug Administration Advisory Committee to the Commissioner. Since 1996 she has been a member of the U.S.-Japan Cooperative Medical Science Program responsible for advising the respective governments on joint research agendas. She is a member of the Institute of Medicine (IOM) of the National Academy of Sciences and serves on the IOM's governing board.
Dr. Cassell is a past president of the American Society for Microbiology (ASM), and was a member of the NIH Director's Advisory Committee and a member of the Advisory Council of the National Institute of Allergy and Infectious Diseases (NIAID) of NIH. She was named to the original Board of Scientific Councilors of the Center for Infectious Diseases, a part of the Centers for Disease Control and Prevention (CDC), and served as chair of the Board. She recently served a three-year term on the Advisory Board of the Director of the CDC and as a member of the Secretary of Health and Human Services Advisory Council of Public Health Preparedness.
Dr. Cassell has been deeply involved in formulating science policy and legislation related to biomedical research and public health. For nine years, she was chair of the Public and Scientific Affairs Board of the ASM and also has served as an adviser on infectious diseases to the White House Office of Science and Technology Policy. She has served on the editorial boards of scientific journals, has authored more than 250 articles and book chapters, and has testified numerous times at Congressional hearings and briefings on infectious diseases, anti-microbial resistance and biomedical research. She has received national and international awards and an honorary degree for her research in infectious diseases.
Dr. Cassell graduated from the University of Alabama in Tuscaloosa and, in 1993, was selected as one of the top 31 female graduates of the 20th century. She obtained her doctorate in microbiology from the University of Alabama at Birmingham and was selected as its 2003 Distinguished Alumnus.